Maternal outcomes at mid-altitudes in anemic pregnant women: Evidence from the WOMAN-2 trial
6 affiliations
- 1Department of Obstetrics and Gynaecology, University of Dar es Salaam, Mbeya College of Health and Allied Sciences, Dar es Salaam, Tanzania
- 2Clinical Trials Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom
- 3Global Institute of Human Development, Shifa Tameer-e-Millat University, Islamabad, Pakistan
- 4Department of Obstetrics and Gynaecology, University of Ibadan College of Medicine Ibadan, Nigeria
- 5National Institute for Medical Research-Tanzania (NIMR)
- 6Department of Obstetrics and Gynaecology, University of Zambia School of Medicine, Lusaka, Zambia
Abstract
Background: High residential altitude is associated with adverse pregnancy outcomes, yet most research has focused on elevations above 2500 meters. There is limited evidence on how altitude impacts maternal health below this threshold, where 99% of the global population resides. We investigated the effect of mid-altitudes on maternal outcomes among women with moderate to severe anemia who delivered in hospitals in four sub-Saharan and Asian countries. Methods: We analysed data from the World Maternal Antifibrinolytic-2 (WOMAN-2) trial, which recruited anaemic women admitted for vaginal delivery across 42 hospital sites in Nigeria, Pakistan, Tanzania, and Zambia. We compared women in mid-altitudes (1,000–2,499 m) with those at low-altitudes (< 1,000 m) using postpartum blood loss as the primary outcome. The key secondary outcome was clinical postpartum haemorrhage (PPH). Additional secondary outcomes included prenatal maternal health indicators (gestational age at labor onset, hypertensive disorders of pregnancy, baseline hemoglobin, severe anemia, and mean arterial pressure [MAP]), as well as intrapartum intervention indicators (assisted delivery, use of medical pain control, and use of oxytocin in labor). We used STATA version 18 for data analysis. We used classical logistic and modified Poisson regressions with cluster-robust standard errors to estimate the odds and risk ratios (RR) for dichotomous outcomes and linear regression with cluster-robust variance to estimate the β coefficients for the continuous outcomes. Results: Of 15,068 women, 4801 (31.9%) delivered at mid-altitude and 10,267 (68.1%) at low-altitudes. Delivery in mid-altitudes did not independently affect postpartum blood loss (β = 37.89 mL; 95% CI: −26.83–102.62), p = 0.243. Mid-altitude delivery compared to low-altitude was independently associated with a 22% lower risk of preterm delivery (aRR = 0.78; 95%CI: 0.73–0.83), p < 0.001, and a 26% lower risk of severe anaemia (aRR = 0.74; 95% CI: 0.68–0.82), p < 0.001. The use of medical pain control was 2.2 times higher (aRR = 2.20; 95% CI: 2.02–2.40), p < 0.001, and the Odds of assisted delivery were 46% more likely (aOR = 1.46; 95% CI: 1.20–1.78) at mid-altitudes compared to low-altitudes. Conclusion: Delivery at mid-altitudes was not independently associated with postpartum blood loss, but generally exhibited more favorable prenatal maternal health indicators and more intrapartum interventions than those delivering at low-altitudes.
Related
- Early pregnancy overweight/obesity and adverse maternal outcomes among pregnant women in Eastern Ethiopia: an ambispective cohort study
- Maternal and Fetal Outcomes of Pregnant Women With Sickle Cell Disease: A Single‐Center Canadian Study
- Generative Artificial Intelligence and Maternal Health Outcomes in Pregnant and Postpartum Individuals
- A randomized controlled double-blinded trial to assess the risk of gestational diabetes mellitus in non-anemic pregnant women who receive oral iron supplementation
- Factors associated with anemia severity among anemic pregnant women attending antenatal care at Mohamed Mooge and Xawaadle health centers, Hargeisa, Somaliland: a cross-sectional study
BibTeX
@article{muganyizi2026maternal,
title = {{Maternal outcomes at mid-altitudes in anemic pregnant women: Evidence from the WOMAN-2 trial}},
author = {Projestine Muganyizi and Amy Brenner and Aasia Kayani and Eni Balogun and Folasade Adenike Bello and Gibson Kagaruki and Haleema Shakur-Still and Ian Roberts and Kiran Javaid and Mwansa Ketty Lubeya and Oladapo Olayemi and Rizwana Chaudhri and Raoul Mansukhani and Vwalika Bellington},
journal = {PLOS One},
year = {2026},
month = sep,
doi = {10.1371/journal.pone.0357033},
url = {https://doi.org/10.1371/journal.pone.0357033},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Maternal outcomes at mid-altitudes in anemic pregnant women: Evidence from the WOMAN-2 trial
AU - Projestine Muganyizi
AU - Amy Brenner
AU - Aasia Kayani
AU - Eni Balogun
AU - Folasade Adenike Bello
AU - Gibson Kagaruki
AU - Haleema Shakur-Still
AU - Ian Roberts
AU - Kiran Javaid
AU - Mwansa Ketty Lubeya
AU - Oladapo Olayemi
AU - Rizwana Chaudhri
AU - Raoul Mansukhani
AU - Vwalika Bellington
PY - 2026
DA - 2026/09/02
JO - PLOS One
DO - 10.1371/journal.pone.0357033
UR - https://doi.org/10.1371/journal.pone.0357033
AB - Background: High residential altitude is associated with adverse pregnancy outcomes, yet most research has focused on elevations above 2500 meters. There is limited evidence on how altitude impacts maternal health below this threshold, where 99% of the global population resides. We investigated the effect of mid-altitudes on maternal outcomes among women with moderate to severe anemia who delivered in hospitals in four sub-Saharan and Asian countries. Methods: We analysed data from the World Maternal Antifibrinolytic-2 (WOMAN-2) trial, which recruited anaemic women admitted for vaginal delivery across 42 hospital sites in Nigeria, Pakistan, Tanzania, and Zambia. We compared women in mid-altitudes (1,000–2,499 m) with those at low-altitudes (< 1,000 m) using postpartum blood loss as the primary outcome. The key secondary outcome was clinical postpartum haemorrhage (PPH). Additional secondary outcomes included prenatal maternal health indicators (gestational age at labor onset, hypertensive disorders of pregnancy, baseline hemoglobin, severe anemia, and mean arterial pressure [MAP]), as well as intrapartum intervention indicators (assisted delivery, use of medical pain control, and use of oxytocin in labor). We used STATA version 18 for data analysis. We used classical logistic and modified Poisson regressions with cluster-robust standard errors to estimate the odds and risk ratios (RR) for dichotomous outcomes and linear regression with cluster-robust variance to estimate the β coefficients for the continuous outcomes. Results: Of 15,068 women, 4801 (31.9%) delivered at mid-altitude and 10,267 (68.1%) at low-altitudes. Delivery in mid-altitudes did not independently affect postpartum blood loss (β = 37.89 mL; 95% CI: −26.83–102.62), p = 0.243. Mid-altitude delivery compared to low-altitude was independently associated with a 22% lower risk of preterm delivery (aRR = 0.78; 95%CI: 0.73–0.83), p < 0.001, and a 26% lower risk of severe anaemia (aRR = 0.74; 95% CI: 0.68–0.82), p < 0.001. The use of medical pain control was 2.2 times higher (aRR = 2.20; 95% CI: 2.02–2.40), p < 0.001, and the Odds of assisted delivery were 46% more likely (aOR = 1.46; 95% CI: 1.20–1.78) at mid-altitudes compared to low-altitudes. Conclusion: Delivery at mid-altitudes was not independently associated with postpartum blood loss, but generally exhibited more favorable prenatal maternal health indicators and more intrapartum interventions than those delivering at low-altitudes.
SN - 1932-6203
ER -